Cellectar Biosciences (CLRB)
NASDAQ:CLRB
Holding CLRB?
Track your performance easily

Cellectar Biosciences (CLRB) Financial Statements

1,265 Followers

Cellectar Biosciences Financial Overview

Cellectar Biosciences's market cap is currently ―. The company's EPS TTM is $-2.708; its P/E ratio is -0.75; Cellectar Biosciences is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $-0.33. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -919.37K$ -21.58M$ -7.51M$ -8.22M$ -8.58M
EBITDA$ -821.88K$ -21.49M$ -7.44M$ -8.18M$ -8.54M
Net Income Common Stockholders$ -919.37K$ -21.58M$ -7.45M$ -8.22M$ -8.58M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 25.87M$ 40.03M$ 9.56M$ 5.15M$ 12.68M
Total Assets$ 29.38M$ 42.91M$ 12.08M$ 6.51M$ 14.84M
Total Debt$ 530.86K$ 548.34K$ 552.98K$ 584.50K$ 599.45K
Net Debt$ -25.34M$ -39.48M$ -9.01M$ -4.57M$ -12.08M
Total Liabilities$ 15.62M$ 16.74M$ 13.43M$ 6.98M$ 7.50M
Stockholders Equity$ 12.38M$ 26.17M$ -1.36M$ -467.00K$ 7.33M
Cash Flow-
Free Cash Flow$ -14.16M$ -13.38M$ -9.86M$ -7.53M$ -7.18M
Operating Cash Flow$ -14.14M$ -13.36M$ -9.60M$ -7.53M$ -7.18M
Investing Cash Flow$ -21.28K$ -21.63K$ -266.76K--
Financing Cash Flow$ 1.00$ 43.85M$ 441.00K-$ 3.00
Currency in USD

Cellectar Biosciences Earnings and Revenue History

Cellectar Biosciences Debt to Assets

Cellectar Biosciences Cash Flow

Cellectar Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis